These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6319866)

  • 21. Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes.
    Demoliou-Mason CD; Barnard EA
    J Neurochem; 1986 Apr; 46(4):1118-28. PubMed ID: 3005504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
    Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
    Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
    Wang XJ; Han JS
    J Neurochem; 1990 Oct; 55(4):1379-82. PubMed ID: 2168937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).
    Ward SJ; Fries DS; Larson DL; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1985 Jan; 107(3):323-30. PubMed ID: 2984010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do nitrous oxide and halothane influence opioid receptor binding in SH-SY5Y human neuroblastoma cells?
    Campbell DJ; Rowbotham DJ; Lambert DG
    Br J Anaesth; 1995 Dec; 75(6):752-5. PubMed ID: 8672325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of halothane and methoxyflurane on regional brain and spinal cord substance P-like and beta-endorphin-like immunoreactivities in the rat.
    Karuri AR; Agarwal RK; Engelking LR; Kumar MS
    Brain Res Bull; 1998 Mar; 45(5):501-6. PubMed ID: 9570720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific binding of mu- and delta-ligands by opiate receptors in the rat brain in the presence of reaferon].
    Panchenko LF; Aliab'eva TN; Petrichenko OB; Bumialis VV; Balashov AM
    Biull Eksp Biol Med; 1988 Sep; 106(9):307-9. PubMed ID: 2844322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
    Tam SW
    Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microtubule disassembly increases the number of opioid receptor binding sites in rat cerebrum membranes.
    Borsodi A; Toth G
    Neuropeptides; 1986 Jul; 8(1):51-4. PubMed ID: 3020468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mu-opioid receptor in the 7315c tumor cell.
    Tocque B; Jacobson AE; Rice KC; Frey EA
    Eur J Pharmacol; 1987 Nov; 143(1):127-30. PubMed ID: 2826184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding characteristics of mu and kappa agonists in rat brain subcellular fractions.
    Monferini E; Adler MW; Simon EJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1295-8. PubMed ID: 6128655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.
    Antkiewicz-Michaluk L; Havemann U; Vetulani J; Wellstein A; Kuschinsky K
    Life Sci; 1984 Jul; 35(4):347-55. PubMed ID: 6087059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin.
    James IF; Chavkin C; Goldstein A
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7570-4. PubMed ID: 6130527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
    Delay-Goyet P; Roques BP; Zajac JM
    Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW; West RE; Miller RJ; Dawson G
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.